5.3 KiB
| title | chunk | source | category | tags | date_saved | instance |
|---|---|---|---|---|---|---|
| Head-twitch response | 3/5 | https://en.wikipedia.org/wiki/Head-twitch_response | reference | science, encyclopedia | 2026-05-05T07:29:09.145592+00:00 | kb-cron |
== Scientific validity == Head twitches do not occur with psychedelics in humans or many other species. In addition, they lack face validity as an animal behavioral proxy of psychedelic effects, in that they bear little resemblance to the human psychedelic experience. In any case, it has been said that head twitches might be a behavioral response to sensory disturbances during hallucinogenic experiences. On the other hand, many drugs that are not hallucinogenic in humans also induce the HTR. Despite the preceding limitations, the assay has strong predictive validity for hallucinogenic effects of serotonin 5-HT2A receptor agonists in humans. There is a strong correlation between the capacity of serotonergic psychedelics to induce head twitches in rodents and their reported potency in inducing hallucinogenic effects in humans. The HTR is easily quantifiable and there is high agreement in counts between independent observers. In addition, there is a low level of within-subject and between-subject variability in induction of the HTR in animals. Nonetheless, while the HTR assay is useful in assessing target engagement, it should not be regarded as a definitive predictor of psychedelic potential.
== Exceptions ==
=== Psychedelics lacking head twitches in animals === There are few or no known examples of serotonergic psychedelics with hallucinogenic effects in humans that do not produce the HTR in animals. It was suggested that one of the only observed exceptions, the LSD prodrug ALD-52 (1-acetyl-LSD), could be explained by species differences in metabolism. However, subsequent research found that ALD-52 actually does produce the HTR. Other possible exceptions, including various 2C psychedelics like 2C-B, 2C-I, and 2C-D, as well as the phenylpiperazine TFMPP, may be explained by these agents having relatively low intrinsic activity at the serotonin 5-HT2A receptor and by species differences in sensitivity to HTR elicitation by serotonin 5-HT2A receptor partial agonists (mice being more sensitive than rats). Dimethyltryptamine (DMT) shows effects on the HTR in mice that are highly strain-dependent, including producing an HTR comparable to other psychedelics, producing an HTR that is much weaker than that of other psychedelics, or producing no HTR at all. These conflicting results may be due to rapid metabolism of DMT and/or other peculiarities of DMT in different species. In contrast to serotonergic psychedelics, oneirogens like harmine and ibogaine do not produce the HTR in rodents.
=== Non-psychedelics inducing head twitches ===
The HTR can be non-specific and can have false positives, with head twitches also produced by some drugs that do not act through serotonin 5-HT2 receptors. Examples of these agents include NMDA receptor antagonists like phencyclidine (PCP), certain benzodiazepines and Z-drugs like estazolam, triazolam, and zopiclone, α2-adrenergic receptor antagonists like yohimbine, muscarinic acetylcholine receptor antagonists like atropine and scopolamine, serotonin 5-HT1A receptor antagonists like WAY-100635 and UH-301, and CB1 receptor antagonists like rimonabant. In the cases of benzodiazepines, rimonabant, and serotonin 5-HT1A receptor antagonists however, this effect appeared to be mediated by indirect or direct activation of serotonin 5-HT2A receptors. Acute lithium administration induces the HTR via increased serotonin release in rodents, whereas chronic administration blunts head twitches in response to psychedelics. A number of other drugs, including the acetylcholine receptor agonist carbachol, opioids, and thyrotropin-releasing hormone (TRH) among others, have also been reported to induce the HTR. Drugs such as the serotonin precursors tryptophan and 5-hydroxytryptophan (5-HTP), serotonin releasing agents (SRAs) like fenfluramine and para-chloroamphetamine (PCA), and other agents like 1-methylpsilocin and 3,4-dimethoxyphenethylamine (DMPEA) stimulate serotonin receptors and can produce head twitches, but are not known to be hallucinogenic in humans. However, at least in the case of 5-HTP, this could be just be due to the very high doses required. It is notable in this regard that hallucinations are reported in a subset of cases of serotonin syndrome, although it is unclear at the present time whether these hallucinations are psychedelic in nature or are of a different etiology. While the SRA and mixed entactogen and psychedelic MDA likewise induces the HTR, findings are mixed and conflicting for the SRA and less hallucinogenic MDMA. The SRA dexfenfluramine produces wet dog shakes in rats, whereas the serotonin reuptake inhibitor fluoxetine has little or no effect on wet dog shakes. Amphetamine as well as para-hydroxyamphetamine (given intracerebroventricularly) can also elicit the HTR at sufficiently high doses. The preceding findings collectively suggest that while the HTR can be a useful indicator as to whether a compound is likely to display hallucinogenic activity in humans, the induction of the HTR does not necessarily mean that a compound will be hallucinogenic. In relation to this, caution should be exercised when interpreting such results.
=== Non-hallucinogenic serotonin 5-HT2A receptor agonists ===